Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
申请人:Instytut Biochemii I Biofizyki Polskiej
Akademii Nauk
公开号:EP2816035A2
公开(公告)日:2014-12-24
The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ΔF508-CFTR, or another mutation of class II.
本发明涉及能够改变突变型CFTR蛋白功能的新型蛋白调节剂及其用于治疗与CFTR蛋白功能失常有关的疾病。本发明提供了纠正突变型CFTR蛋白细胞改变的组合物、药物制剂和方法,其中CFTR突变是ΔF508-CFTR突变或II类的另一种突变。